ABSTRACT
Introduction
Ventilator-associated pneumonia (VAP) is pneumonia which develops 48 hours after intubation in a subject supported by mechanical ventilation without documented pneumonia or findings suggestive of pneumonia during intubation. VAP is a complication of intubation and mechanical ventilation. (1, 2) VAP occurs in 9-27% of all intubated patients. (3, 4) VAP is the leading cause of nosocomial mortality for patients with respiratory failure and crude mortality rates are reported between 20-70%. (5) Clinical suspicion of pneumonia is the first step in any evaluation of patients with possible VAP. Diagnosis of VAP is quite difficult and there is no established consensus on the appropriate diagnostic strategy. Although the pre-sence of radiologically observed infiltrates in a subject with fever, leukocytosis or purulent tracheobronchial secretion has a substantially high sensitivity for the diagnosis of VAP, its specificity is low. (6) In addition, the controversy remains about selection of the methods for obtaining lower respiratory tract secretions, such as endotracheal aspirate, bronchoalveolar lavage (BAL) or protected brush specimen. The most important dilemma in the diagnosis of VAP, based on only clinical findings, is overdiagnosis. On the other hand, several studies have shown that immediate initiation of appropriate antibiotics was associated with reduced mortality. (7, 8) Strategies have been proposed for the identification of lowrisk patients who can receive short-term therapy, thereby minimizing the risk of delayed antimicrobial treatment as well as the risks associated with overtreatment. Clinicians need to make immediate treatment decisions in the presence of clinical suspicion of VAP based on classical criteria or a clinical pulmonary infection score (CPIS) during the initial evaluation of the patient. Pugin et al. combined information on body temperature, white blood cell count (WBC), volume and appearance of tracheal secretions, oxygenation, chest X-ray, and tracheal aspirate culture into a clinical pulmonary infection score. (9) This score summarizes the major features used to diagnose pneumonia and gives them relative significance. The aim of our study is to calculate sensitivity, specificity, positive and negative predictive values of CPIS in patients with VAP, diagnosed with quantitative BAL cultures.
Materials and methods
A total of 50 patients, older than 18 years of age, with clinically suspected VAP and having no prior antibiotic therapy or no change in current antibiotic therapy within the last three days before BAL, were enrolled in the study. These patients received mechanical ventilation therapy for more than 48 hours and were followed up in the Reanimation ICU (surgical-medical intensive care unit). The study was approved by Uludaò Univ. School of Medicine's Ethics Committee. Signed informed consent was obtained from all patients. Clinical suspicion criteria for VAP were defined as the presence of new or progressive infiltration in chest radiography and presence of at least two of the following criteria: fever (ě38 0 C), leukocytosis (ě10000 per mm 3 ) and purulent tracheobronchial secretion. (1, 10) During clinical suspicion of ventilator associated pneumonia blood cultures were obtained twice after a 30 mininterval, and the following protocol was performed, in the same sequence, in all cases within 12 hours. First, endotracheal aspiration was performed using a sterile technique. The catheter was introduced through the endotracheal tube to a depth of at least 30 cm. Gentle aspiration was performed without instilling saline solution. The first aspirate was discarded, and the second was collected for evaluation. (11) BAL was performed by wedging the bronchoscope in the subsegmental bronchus of the most compromised lobe seen on chest radiography or, in cases of diffuse radiologic presentation, in the posterior bronchus of the lower lobe. As little topical lidocaine as possible was used so as not to interfere with bacterial growth (never >20 mg per bronchus). Aspiration of secretions through the bronchoscope was avoided. Three aliquots were separately In 41 cases with a diagnosis of VAP, CPIS scores during diagnosis were 6±2 (3-9) (median± QR, maximumminimum) and 7±2 (2-9) at the 72 nd hour,. In cases with no diagnosis of VAP, the CPIS scores were found to be 6±2 (4-8) and 5±3 (2-7), respectively. There was no significant difference between the VAP group and the non-VAP group. The differences (delta) between the initial versus 72 nd h CPIS scores were not statistically significant when comparison was made between VAP and non-VAP patients. In 14 cases with a diagnosis of earlyonset VAP, CPIS scores during diagnosis were 6±3(4-8) (median± QR, maximum-minimum) and 7±4 (2) (3) (4) (5) (6) (7) (8) at the 72 nd hour. In cases with a diagnosis of late-onset VAP, the CPIS scores were found to be 6±2 (3-9) and 7±2 (3-9), respectively. There was no significant difference between the early-onset VAP group and the late-onset VAP group. The differences (delta) between the initial versus 72 nd h CPIS scores were not statistically significant when comparison was made between early-onset and late-onset VAP.
There was no significant correlation between APACHE II score and CPIS at 24 th and 72 nd hour.
Discussion
The diagnosis of VAP is still controversial. In some studies it was demonstrated that quantitative evaluation of lower (21) In this study sensitivity was 76%, specificity was 15%, PPV was 31%, and NPV was 55%, under the same conditions. Comparison of the two studies above highlights a higher sensitivity but lower specificity in our study. In studies where CPIS was evaluated for pneumonia diagnosis at 72 nd hour of diagnosis, Schurink et al. found sensitivity as 83% and specificity as 17%, using 6 parameters (Modified Pugin Criteria) and the threshold value was >5 for the evaluation of CPIS. (22) In this study, the best threshold value was found to be >7 by ROC analysis and according to this threshold value sensitivity of CPIS was found to be 41%, specificity was 77%, PPV was 80% and NPV was 36% for the diagnosis of pneumonia. In the study of Luyt et al. it was reported that sensitivity was 89%, specificity was 47%, PPV was 57% and NPV was 84% when the CPIS was evaluated using 7 parameters and CPIS threshold value was >6. (23) In addition, in this study the best CPIS threshold value was found to be >7 by ROC analysis and on the basis of this value sensitivity was found to be 75% and specificity was 66%. On the other hand, in this study we found the sensitivity as 87%, specificity as 22%, PPV as 55% and NPV as 62% for CPIS, evaluated using 7 parameters and a threshold value of >6. A CPIS reference of >7, showed that sensitivity was 100%, specificity was 23%, PPV was 31%, and NPV was 100%. Comparison of our study with the study of Luyt et al . , (23) where the same number of parameters were used demonstrated that sensitivity and PPV were similar, whereas specificity and NPV were lower. In other studies it was reported that sensitivity varied between 30 and 77%, while specificity varied between 42 and 85%, when CPIS threshold value was >6. (24) (25) (26) Evaluation of the results of our study and other studies demonstrated that sensitivity and specificity ratios did not attain the desired clinical levels. On the other hand it is impossible to make a precise comparison of these studies.
Factors that play a role in this study could be explained by the number of parameters and the differences in obtaining microbiological samples, which were used for the calculation of CPIS, differences in pneumonia ratios of the study groups, differences in number of patients who used antibiotics during the diagnosis, difference of the method that was used as a golden standard for the diagnosis of pneumonia in the studies and heterogeneous patient populations of the study groups. (20) (21) (22) (23) (24) (25) (26) Studies conducted on traumatized and burned patients clearly demonstrated that the effects of differences in the patient groups on results. (20) (21) (22) (23) (24) Two limitations of our study should be noted. Firstly, the size of the subgroup of patients without VAP and that could have altered the results. Secondly, our patients without VAP (control group) had higher APACHE II scores. As a consequence, results of CPIS studies and our study do not supersede conventional clinical criteria, which were first defined by Johanson et al. (27) We believe that, results of CPIS should be evaluated carefully in the clinical setting.
